These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9844581)

  • 1. Cytotoxic effects of quinoxaline derivatives on human cancer cell lines.
    Yoo HW; Lee YS; Suh ME; Kim DJ; Park SW
    Arch Pharm (Weinheim); 1998 Oct; 331(10):331-3. PubMed ID: 9844581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cytotoxicity of 2-methyl-4, 9-dihydro-1-substituted-1H-imidazo[4,5-g]quinoxaline-4,9-diones and 2,3-disubstituted-5,10-pyrazino[2,3-g]quinoxalinediones.
    Yoo HW; Suh ME; Park SW
    J Med Chem; 1998 Nov; 41(24):4716-22. PubMed ID: 9822542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives.
    Hajri M; Esteve MA; Khoumeri O; Abderrahim R; Terme T; Montana M; Vanelle P
    Eur J Med Chem; 2016 Nov; 124():959-966. PubMed ID: 27770736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
    Moarbess G; Deleuze-Masquefa C; Bonnard V; Gayraud-Paniagua S; Vidal JR; Bressolle F; Pinguet F; Bonnet PA
    Bioorg Med Chem; 2008 Jul; 16(13):6601-10. PubMed ID: 18513976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization and Biological Evaluation of Some Quinoxaline Derivatives: A Promising and Potent New Class of Antitumor and Antimicrobial Agents.
    Al-Marhabi AR; Abbas HA; Ammar YA
    Molecules; 2015 Nov; 20(11):19805-22. PubMed ID: 26540036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
    Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
    Alswah M; Bayoumi AH; Elgamal K; Elmorsy A; Ihmaid S; Ahmed HEA
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29280968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxic activities of 8-alkyl or 8-aryl-8,9-dihydro-7H-isoindolo[5,6-g]quinoxaline-7,9-diones.
    Jung JK; Jung EK; Nam-Goong K; Cho JS; Kim HM; Park SG; Yoo YA; Kwon JH; Lee HS
    Arch Pharm Res; 2006 Apr; 29(4):276-81. PubMed ID: 16681031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antitumor activity of new quinoxaline derivatives.
    Corona P; Carta A; Loriga M; Vitale G; Paglietti G
    Eur J Med Chem; 2009 Apr; 44(4):1579-91. PubMed ID: 18774202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile synthesis of C6-substituted benz[4,5]imidazo[1,2-a]quinoxaline derivatives and their anticancer evaluation.
    Singh R; Kumar R; Pandrala M; Kaur P; Gupta S; Tailor D; Malhotra SV; Salunke DB
    Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000393. PubMed ID: 33749032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel N-oxides as bioreductive drugs.
    Naylor MA
    Oncol Res; 1994; 6(10-11):483-91. PubMed ID: 7620216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines.
    Desplat V; Vincenzi M; Lucas R; Moreau S; Savrimoutou S; Pinaud N; Lesbordes J; Peyrilles E; Marchivie M; Routier S; Sonnet P; Rossi F; Ronga L; Guillon J
    Eur J Med Chem; 2016 May; 113():214-27. PubMed ID: 26945110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative Stress Modulation and Radiosensitizing Effect of Quinoxaline-1,4-Dioxides Derivatives.
    Silva L; Coelho P; Teixeira D; Monteiro A; Pinto G; Soares R; Prudêncio C; Vieira M
    Anticancer Agents Med Chem; 2020; 20(1):111-120. PubMed ID: 31746309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoxaline chemistry. Part 5. 2-(R)-benzylaminoquinoxalines as nonclassical antifolate agents. Synthesis and evaluation of in vitro anticancer activity.
    Loriga M; Fiore M; Sanna P; Paglietti G
    Farmaco; 1996; 51(8-9):559-68. PubMed ID: 8930109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
    Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
    Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of New Quinoxaline Derivatives of Dehydroabietic Acid as Potential Antitumor Agents.
    Gu W; Wang S; Jin X; Zhang Y; Hua D; Miao T; Tao X; Wang S
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28696365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
    Abbas HA; Al-Marhabi AR; Eissa SI; Ammar YA
    Bioorg Med Chem; 2015 Oct; 23(20):6560-72. PubMed ID: 26420384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents.
    Rodrigues FA; Bomfim Ida S; Cavalcanti BC; Pessoa Cdo Ó; Wardell JL; Wardell SM; Pinheiro AC; Kaiser CR; Nogueira TC; Low JN; Gomes LR; de Souza MV
    Bioorg Med Chem Lett; 2014 Feb; 24(3):934-9. PubMed ID: 24398294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.
    Tseng CH; Chen YR; Tzeng CC; Liu W; Chou CK; Chiu CC; Chen YL
    Eur J Med Chem; 2016 Jan; 108():258-273. PubMed ID: 26686931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers.
    El Newahie AMS; Nissan YM; Ismail NSM; Abou El Ella DA; Khojah SM; Abouzid KAM
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30934622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.